Dynavax Technologies Corp (NASDAQ: DVAX) reported Q2 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $3.05 million versus the consensus estimate of $2.26 million.

For earnings history and earnings-related data on Dynavax Technologies Corp (DVAX) click here.